WHO Model Prescribing Information: Drugs Used in HIV-Related Infections
(1999; 58 pages) Ver el documento en el formato PDF
Índice de contenido
Ver el documentoPreface
Abrir esta carpeta y ver su contenidoOpportunistic infections
Cerrar esta carpetaRespiratory disease
Ver el documentoPneumonia due to Pneumocystis carinii (PCP)
Ver el documentoPulmonary tuberculosis
Ver el documentoHistoplasmosis and coccidioidomycosis
Ver el documentoAspergillosis
Abrir esta carpeta y ver su contenidoNeurological disorders
Abrir esta carpeta y ver su contenidoOpthalmological complications
Abrir esta carpeta y ver su contenidoFebrile illness
Abrir esta carpeta y ver su contenidoGastrointestinal tract/diarrhoeal disease
Abrir esta carpeta y ver su contenidoMucocutaneous and cutaneous eruptions
Abrir esta carpeta y ver su contenidoDrugs
Ver el documentoBack Cover
 

Respiratory disease

From the early stage of HIV infection, patients are particularly vulnerable to common pathogens of the respiratory tract. As the immune system continues to deteriorate, they become increasingly susceptible to tuberculosis, non-specific mycobacterial infections, and systemic mycoses. Pneumonia due to Pneumocystis carinii is relatively common, in industrialized countries. Pulmonary tuberculosis is particularly common in developing countries.

Bacterial infection:

Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus

Mycobacterial infection:

M. tuberculosis, M. avium-intracellulare, M. kansasii, M. xenopi.

Fungal infection:

Pneumocystis carinii pneumonia Cryptococcus neoformans, Histoplasma capsulatum, Coccidioides immitis, Aspergillus species Penicillium marnefii.

Viral infection:

Cytomegalovirus.

Non-infectious disorders:

Non-Hodgkin’ s lymphoma, Kaposi’s sarcoma, lymphoid interstitial pneumonitis, non-specific interstitial pneumonitis.

Summary of main respiratory infections

 

Symptoms & signs

Laboratory investigations

Radiological changes

1st line treatment

Bacterial pneumonia

fever cough, dyspnoea sputum production increased respiratory rate

leucocytosis blood cultures may be positive

consolidation (may be lobar)

amoxicillin or according to national guidelines & local sensitivities

PCP

dyspnoea (esp. on exertion) fever dry cough normal auscultation

haemo-gas analysis: hypoxia bronchial lavage (if available)

peri-hilar shadowing (ground glass haze) interstitial infiltrates

high dose SMZ/TMP 2-3 weeks then continual maintenance

Tuberculosis

general malaise weight loss night sweats fever cough sputum production (may be blood- stained) lymphadenopathy

sputum examination for AFBs lymph node aspiration for AFBs culture, where possible

upper lobe consolidation +/- cavities mediastinal lymphadenopathy pleural effusion (Xray often atypical)

according to national TB guidelines or 2RHEZ/4RH* (for new cases, recurrences require longer and more aggressive treatment**)

* Rifampicin and isoniazid for 6 months supplemented in the first 2 months by pyrazinamide and ethambutol

** Treatment is based on a five drug regime

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 24 abril 2012